この記事の翻訳を準備しています。それまでの間、英語の原文を表示します。
ビジネス · 2019/9/111 分で読めます
Use of Fecal Microbiota for Transplantation to Treat Clostridium difficile Infection Not Responsive to Standard Therapies; Public Hearing; Request for Comments
ローカル自動翻訳 · 情報源の原言語
概要
The Food and Drug Administration (FDA, the Agency, or we) is announcing a public hearing to obtain input on the use of fecal microbiota for transplantation (FMT) to treat Clostridium difficile infection not responsive to standard therapies. FDA will consider scientific data and other information from the public hearing as we continue to consider ways to support the development of FMT to treat C. difficile infection not responsive to standard therapies and the impact of the enforcement policy on such development.
情報源の原言語: Federal Register — Food and Drug Administration原文の発表を開く →